Results from the Phase 3 CheckMate -67T trial will be presented in a late-breaking oral presentation at ASCO GU 2024. 3 Summer "Power Patterns" Are About to Trigger (One With 90% Win Rate) - Get The ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Gabby Landsverk Every time Gabby publishes a story, you’ll get an alert straight to your inbox!
Facility-Level Disparities in Radiation Use for Limited-Stage Small Cell Lung Cancer Patient-controlled analgesia (PCA) has been considered for managing cancer pain; however, limited research has been ...
An NAD+ drip that leaves you hot, achy and running to the toilet to vomit? That’s so 2024. NAD+ — a coenzyme in involved in things like energy production and DNA repair — has been the hot biohacking ...
In the ever-evolving world of wellness, it’s no surprise that intravenous (IV) therapies have surged in popularity. Among these, NAD (nicotinamide adenine dinucleotide) IV drips have become the talk ...